Semaglutide and Tirzepatide are two of the most powerful fat-loss compounds available today. Originally developed as diabetes medications, both have become extremely popular in bodybuilding and weight loss circles for their ability to significantly suppress appetite and drive rapid, sustainable fat loss.
This guide compares both head-to-head: mechanism of action, fat loss effectiveness, dosing protocol, side effects and which one is right for your goals.
How They Work
Semaglutide is a GLP-1 receptor agonist. It mimics the glucagon-like peptide-1 hormone that your body naturally releases after eating. By activating GLP-1 receptors, it slows gastric emptying, reduces appetite and increases insulin secretion — resulting in dramatically lower caloric intake.
Tirzepatide goes one step further. It is a dual GLP-1 and GIP receptor agonist. GIP (glucose-dependent insulinotropic polypeptide) works synergistically with GLP-1 to enhance insulin response and fat metabolism even more effectively. This dual action is why Tirzepatide generally outperforms Semaglutide for raw fat loss.
Side-by-Side Comparison
| Property | Semaglutide | Tirzepatide |
|---|---|---|
| Receptor Target | GLP-1 only | GLP-1 + GIP (dual) |
| Average Fat Loss (clinical) | ~15% body weight | ~20–22% body weight |
| Injection Frequency | Once weekly | Once weekly |
| Starting Dose | 0.25mg/week | 2.5mg/week |
| Maintenance Dose | 1–2.4mg/week | 5–15mg/week |
| Nausea Risk | Moderate | Moderate–High |
| Muscle Preservation | Moderate | Better (due to GIP) |
Fat Loss Results: Which Wins?
Clinical trials are clear: Tirzepatide produces greater fat loss than Semaglutide. The SURMOUNT-1 trial showed Tirzepatide at 15mg/week produced an average body weight reduction of 22.5% over 72 weeks. Semaglutide at its highest dose of 2.4mg/week (STEP-1 trial) produced ~15% weight reduction in the same timeframe.
💡 Important: Neither compound preserves muscle as well as resistance training + adequate protein intake. If fat loss is your goal, stack either peptide with a high-protein diet (1.6–2g/kg bodyweight) and continue lifting to minimize muscle loss.
Dosing Protocol
Semaglutide
- Weeks 1–4: 0.25mg once weekly
- Weeks 5–8: 0.5mg once weekly
- Weeks 9–12: 1mg once weekly
- Weeks 13+: 1.7mg–2.4mg once weekly (as tolerated)
Tirzepatide
- Weeks 1–4: 2.5mg once weekly
- Weeks 5–8: 5mg once weekly
- Weeks 9–12: 7.5mg once weekly
- Weeks 13+: 10–15mg once weekly (as tolerated)
Both are injected subcutaneously (abdomen, thigh or upper arm) once weekly, on the same day each week.
Side Effects
The most common side effect for both is gastrointestinal — nausea, vomiting, diarrhea and constipation. These are most pronounced when starting or increasing dose and typically subside within a few weeks. Slow dose escalation is essential to minimize GI side effects.
Which Should You Choose?
Choose Semaglutide if you're newer to GLP-1 peptides, want a proven compound with extensive research, or have had issues with GI side effects before.
Choose Tirzepatide if maximum fat loss is your goal, you've used Semaglutide before and want stronger results, or you want better muscle preservation alongside fat loss.
Shop Semaglutide & Tirzepatide
Research-grade GLP-1 peptides available now. Fast worldwide shipping.
Shop Peptides →⚠️ Disclaimer: This article is for educational and research purposes only. Always consult a qualified healthcare professional before use. GOD MUSCLE GEARS does not provide medical advice.
